U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240987) titled 'Mesenchymal Stem Cells for Chronic Kidney Diseases: A Randomized Controlled Trial' on Nov. 17.
Brief Summary: This study will evaluate the effect of intravenous injection of umbilical cord tissue derived mesenchymal stem cells (UMSCs) on the improvement of renal function in patients with chronic kidney disease (CKD) at stage 3 or 4, with the change of estimated glomerular filtration rate (eGFR) as the primary endpoint, and other changes in renal function laboratory indicators, changes in other organ system function laboratory indicators, and adverse reaction events as secondary endpoints. This trial aims to further evaluate the effi...